This Dividend Stock Outperformed the Nasdaq Last Year Again
A healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...
Evaluate historical worst drawdowns for index funds and translate insights into practical risk controls and withdrawal planning.
14,434 articlesA healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...
The United States plans to deploy Merops, an AI-powered anti-drone system, to the Middle East to counter Iranian Shah...
As Bitcoin prices turned volatile, Strategy—formerly MicroStrategy—pushed a high-stakes financing strategy that boost...
Institutional buyers are quietly backing a select set of artificial intelligence (ai) stock for 2026. This deep dive ...
SanDisk shares jumped on fresh momentum as data-center demand and NAND constraints propel a potential multi-year rall...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
A Guggenheim note argues Oracle's near-term cash burn from AI infrastructure will flip to a strong free cash flow wat...
XRP’s on-chain activity jumped to about 2.75 million daily transactions, while the token’s price stayed stubbornly ra...
Two new lawsuits filed by Anthropic target the Department of Defense, arguing for stricter controls on how its Claude...
Permanent Portfolio's Michael Cuggino argues Meta can invest heavily in AI without sacrificing profits. He emphasizes...
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
U.S. lawmakers pledge rigorous oversight as the DOJ expands its probe into Binance’s sanctions compliance. The move s...